MedPath

Role of Probiotics in Helicobacter pylori (H. Pylori) Eradication?

Phase 3
Completed
Conditions
Helicobacter Pylori
Registration Number
PACTR202304859303467
Lead Sponsor
Theodor BIlharz REasearch Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
159
Inclusion Criteria

Symptomatic patients who were positive H Pylori stool antigen and had never been treated for H.Pylori.

Exclusion Criteria

Patients below 18 years or above 80 years of age
previously received H. pylori eradication therapy
use of antimicrobials or medications that might interfere with H Pylori stool antigen detection( like PPI or H2 blockers use within the previous 2 weeks of stool testing)
previous incidents of gastric or duodenal bleeding, gastric surgery, gastric malignancy, or other life-threatening conditions
unwilling to give consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.